Clinical Trials for Crohn&Amp;#39;s

A Double-Blind, Randomized, Placebo-Controlled Phase II Clinical Trial to Evaluate the Safety and Efficacy of L2-01 in Subjects With Crohn's Disease

NCT ID: NCT07010926

This clinical trial is exploring a new treatment called L2-01 for people with Crohn's Disease, a condition that causes inflammation in the digestive tract. The goal of the study is to see if L2-01,...